Pharma Acquisitions
3 trends tracked about this subject — the full history, oldest to newest below.
↑ Rising
Business
Merck KGaA’s $11B+ acquisition of Bio-Techne reshapes the life sciences toolkit market—here’s why it matters now
7 sources
7 articles
v 5
just now
◼ Archived
Business
🔮 fades ✓
AbbVie’s $10.9B bid for Apogee Therapeutics reshapes biotech M&A landscape overnight
5 sources
6 articles
v 3
2d ago
◼ Archived
Business
🔮 fades ✓
AbbVie’s $10.9B bid for Apogee Therapeutics signals a high-stakes bet on next-gen autoimmune treatments—including a potential Dupixent rival.
6 sources
6 articles
v 4
2d ago